Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.31 CNY 1.71%
Market Cap: 8.2B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note

Net Margin
Jiangsu Kanion Pharmaceutical Co Ltd

11.5%
Current
10%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
11.5%
=
Net Income
526.4m
/
Revenue
4.6B

Net Margin Across Competitors

Country CN
Market Cap 8.3B CNY
Net Margin
12%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 793.7B USD
Net Margin
19%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.4T DKK
Net Margin
35%
Country US
Market Cap 385.5B USD
Net Margin
17%
Country US
Market Cap 260.6B USD
Net Margin
22%
Country CH
Market Cap 213.6B CHF
Net Margin
20%
Country UK
Market Cap 171.2B GBP
Net Margin
13%
Country CH
Market Cap 183.5B CHF
Net Margin
33%
Country US
Market Cap 160.4B USD
Net Margin
7%

Profitability Report

View the profitability report to see the full profitability analysis for Jiangsu Kanion Pharmaceutical Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
11.5%
=
Net Income
526.4m
/
Revenue
4.6B
What is the Net Margin of Jiangsu Kanion Pharmaceutical Co Ltd?

Based on Jiangsu Kanion Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of 11.5%.